TMS THERAPY
FDA-cleared, non-medication depression treatment
Daniel Hageman
The American Academy of Pediatrics recently recommended universal depression screening standards for children and teens from ages 10 to 21. Many teens don’t have access to their own mental health specialists such as psychologists or psychiatrists, so this new recommendation makes depression screenings more accessible through a primary care physician when teens and children go to the doctor for annual or sports physicals.
The American Academy of Pediatrics recently recommended universal depression screening standards for children and teens from ages 10 to 21. Many teens don’t have access to their own mental health specialists such as psychologists or psychiatrists, so this new recommendation makes depression screenings more accessible through a primary care physician when teens and children go to the doctor for annual or sports physicals.
An estimated 1 in every 5 teens will experience a depressive episode, but they are often undiagnosed and depressive symptoms can be dismissed as “growing pains” or “teenage moodiness.” But teens are just as susceptible to depression as adults are, and many symptoms are the same for both age groups :
However, caregivers, educators, mentors, and loved ones of teens should also be on the lookout for these additional signs:
Teens may also be more susceptible to experience depression if they:
Currently, teens seeking treatment for depression are limited to either psychotherapy or medication. Transcranial Magnetic Stimulation (TMS) Therapy may be another option for those teens that are struggling with depression. TMS Therapy works by delivering magnetic pulses to specific areas of the brain involved in mood regulation – areas known to be underactive in those diagnosed with MDD. The magnetic pulses stimulate brain cells, thereby improving the brain’s ability to regulate mood.
Although Transcranial Magnetic Stimulation (TMS) Therapy is not yet indicated for use on persons under the age of 22, clinical trials are currently underway to test the efficacy on children and teenagers from the ages of 12-21 who have been treatment resistant to medication. As a provider of TMS Therapy and observing the effectiveness of this treatment, we are hopeful that the FDA will lower the age indication for treatment so that children and teens struggling with depression will be able to consider TMS Therapy as a treatment option.
Take our 6 question quiz to see if TMS therapy could be right for you
Subscribe for mental health, self-care, and TMS therapy updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook TMS supports an accessible internet. If you have any questions about our accessibility features, please contact us at
866.928.6076 and/or info@greenbrooktms.com.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.